샘플 요청 목록

 카트 문의
시장보고서
상품코드
1777644

세계의 단위 용량 제조 시장

Unit Dose Manufacturing
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 375 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 단위 용량 제조 시장은 2030년까지 1,348억 달러에 도달

2024년에 767억 달러로 추정되는 세계의 단위 용량 제조 시장은 2024-2030년에 CAGR 9.9%로 성장하며, 2030년에는 1,348억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석하고 있는 부문의 하나인 인하우스는 CAGR 8.5%를 기록하며, 분석 기간 종료시에는 817억 달러에 달할 것으로 예측됩니다. 아웃소싱 분야의 성장률은 분석 기간 중 CAGR 12.2%로 추정됩니다.

미국 시장은 209억 달러, 중국은 CAGR 13.2%로 성장 예측

미국의 단위 용량 제조 시장은 2024년에 209억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 272억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 13.2%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 7.2%와 8.6%로 예측됩니다. 유럽에서는 독일이 CAGR 7.7%로 성장할 것으로 예측됩니다.

세계의 단위 용량 제조 시장 - 주요 동향과 촉진요인 정리

정밀 투여로의 전환이 의약품 포장의 전망을 재정의하다?

의약품의 안전성, 투약의 정확성, 규제 준수에 대한 중요성이 강조되면서 제약 및 헬스케어 분야에서 단위 용량 제조의 채택이 빠르게 진행되고 있습니다. 단위 용량 포장은 개별적으로 포장되고 라벨이 부착된 약품의 용량을 1회용으로 설계되어 환자의 안전성을 높이고 투약 오류의 위험을 줄일 수 있습니다. 이 형식은 정확한 조제가 치료 성과 향상과 약물 부작용 최소화에 중요한 역할을 하는 병원 및 장기 요양 환경에서 특히 중요해지고 있습니다. 전 세계 의료 시스템이 린 운영, 자동화, 디지털화를 점점 더 많이 도입하고 있는 가운데, 단위 용량 제조는 효율적인 투약 관리의 핵심으로 각광받고 있습니다. 제약사, 의약품 제조 수탁기관(CMO), 의료기관은 경구용 고형제부터 주사제, 흡입제까지 다양한 제형에 대응할 수 있는 자동 단위 용량 생산 시스템에 투자하고 있습니다. 이 포맷은 바코드 스캔, 전자건강기록(EHR), 투약 추적 시스템과 호환되어 그 매력을 더욱 높이고 있습니다. 규제 당국이 라벨링, 추적성, 공급망 투명성에 대한 관리를 강화하는 가운데, 단위 용량 제조는 현대 의약품 물류에 필수적인 요소로 부상하고 있습니다.

환자 안전과 병원의 효율성이 단위 용량 포장의 급증에 박차를 가하는 이유는 무엇인가?

병원, 진료소, 외래 진료 센터는 의료 실수를 줄이고, 워크플로우를 간소화하고, 투약 프로세스를 최적화해야 한다는 압박을 받고 있습니다. 단위 용량 포장은 의료진의 수작업을 최소화하고, 명확하게 라벨이 부착되어 있으며, 부정 개봉을 방지하고, 바로 사용할 수 있는 투약 단위를 제공함으로써 이러한 목표를 직접적으로 지원합니다. 이는 특히 입원 병동이나 응급실 등 시간과의 싸움인 약물 투여와 직원들의 업무 부담이 큰 문제가 되는 대량의 약물을 취급하는 환경에서 중요합니다. 또한 단위 용량 형식은 의료진이 바코드를 사용하여 정확한 용량을 신속하게 확인할 수 있으며, 교차 오염 및 오투약 가능성을 낮출 수 있습니다. 또한 투약 요법이 점점 더 개인화되고 복잡해짐에 따라 단위 용량 시스템은 대량 포장이나 수작업에 의존하지 않고도 개별 환자의 필요에 따라 치료를 조정할 수 있는 유연성을 제공합니다. 정확한 투약이 특히 중요한 소아 및 노인 의료에서 단위 용량 솔루션은 안전성을 향상시키고, 규정 준수를 간소화하며, 위험을 줄입니다. 또한 단위 용량 모델은 재고 관리 및 폐기물 감소를 지원하여 병원이 의료의 질을 유지하면서 의약품 비용을 관리할 수 있는 방법을 제공합니다. 이러한 복합적인 장점으로 인해 의료 서비스 프로바이더는 급성기 및 만성기 치료 제공 모델에 단위 용량 형식을 통합하도록 장려하고 있으며, 그 결과 전체 의료 기관에 대한 수요가 가속화되고 있습니다.

자동화와 스마트 패키징 기술이 단위 용량 제조를 바꿀 수 있는가?

기술 혁신은 단위 용량 제조의 기능을 확장하고 현대화하는 데 있으며, 혁신적인 역할을 하고 있습니다. 자동화가 최전선에 있으며, 현재 포장 라인은 최소한의 인력 개입으로 개별 단위의 고속 충전, 라벨링, 밀봉 및 검사를 할 수 있습니다. 로봇 시스템과 AI 지원 이미지 검사 툴은 일관된 품질관리를 보장하고, 모듈식 생산 라인은 다양한 제형 및 포장 사양에 대응하기 위한 신속한 재구성을 가능하게 합니다. RFID 태그, QR코드, 시간-온도 표시기 등 스마트 패키징 기술도 단위 용량 형식에 통합되어 공급망 전체에 걸쳐 실시간 추적 및 확인이 가능합니다. 이러한 기능은 환자 안전성을 높이고, 재고 가시성을 향상시키며, 위조 방지 규정을 준수할 수 있도록 지원합니다. 병원 EHR 및 약국 관리 소프트웨어와의 디지털 통합을 통해 처방, 조제, 관리의 원활한 연계가 가능해져 실수를 줄이고 효율성을 더욱 높일 수 있습니다. 지속가능성 측면에서 제조업체는 생분해성 필름과 재활용 가능한 재료를 찾고 단위 용량 포장이 환경 목표에 부합하도록 노력하고 있습니다. 이러한 발전은 단위 용량 제조를 보다 적응력 있고 효율적이며 지능적으로 만들어 제약회사와 헬스케어 시스템이 안전성, 추적성, 운영 우수성에 대한 진화하는 기대에 부응할 수 있도록 돕고 있습니다.

세계 단위 용량 제조 시장의 성장을 가속하는 요인은 무엇인가?

단위 용량 제조 시장의 성장은 기술 통합, 진화하는 의료 관행, 규제 역학, 환자 안전의 필요성과 밀접한 관련이 있는 몇 가지 요인에 의해 주도되고 있습니다. 핵심 성장 요인은 정확한 투약과 추적 가능한 조제가 가장 필요한 병원 및 장기 요양 환경에서 실수 없는 자동 투약으로 전환하고 있다는 점입니다. 또한 외래 환자 및 재택치료의 확대는 환자와 간병인의 번거로움을 줄여주는 편리하고 계량화된 일회용 투약 형식에 대한 수요를 촉진하고 있습니다. 제약사들은 특히 위험도가 높은 대량 의약품의 경우, 내부 업무에 과도한 부담을 주지 않고 수요에 대응하기 위해 단위 용량 생산을 전문으로 하는 CMO와의 제휴를 늘리고 있습니다. 특히 북미와 유럽에서 의약품 라벨링, 연속성 및 안전 포장에 대한 규제 의무화로 인해 채택이 더욱 가속화되고 있습니다. 이와 함께 포장 자동화, 스마트 추적 및 데이터 통합의 기술 발전으로 인해 확장성이 향상되고 단위 용량 생산이 더 많은 제약회사에서 쉽게 이용할 수 있게 되었습니다. 의료기관의 비용 효율성과 폐기물 감소에 대한 관심이 높아지는 것도 중요한 요인이며, 단위 용량 포장은 재고 관리와 자원 최적화에 효과적인 것으로 입증되었습니다. 의료 시스템이 보다 안전하고 효율적인 약물전달 모델을 추구함에 따라 이러한 힘들이 종합적으로 세계 단위 용량 제조 시장의 지속적인 성장을 촉진하고 있습니다.

부문

소싱(인하우스, 아웃소싱); 제품(액체 단위 용량, 고체 단위 용량, 기타); 최종 사용(독립 약국, 장기요양시설, 병원, 기타)

조사 대상 기업의 예

  • Advanced Radiant Systems
  • Advanced Distributor Products(ADP)
  • Airtherm
  • Armstrong International Inc.
  • Beacon Morris
  • Brasch Manufacturing Company, Inc.
  • Daikin Industries Ltd.
  • Detroit Radiant Products
  • Dunham-Bush Limited
  • Goodman Manufacturing
  • Johnson Controls International Plc
  • KING ELECTRICAL MFG. CO
  • Kroll Energy GmbH
  • Lennox International Inc.
  • LG Electronics Inc.
  • Marley Engineered Products
  • Mitsubishi Electric Corporation
  • Modine Manufacturing Company
  • New York Blower Company
  • Reznor(Nortek Global HVAC)
  • Rheem Manufacturing Company
  • Trane Technologies plc

AI 통합

당사는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.08.06

Global Unit Dose Manufacturing Market to Reach US$134.8 Billion by 2030

The global market for Unit Dose Manufacturing estimated at US$76.7 Billion in the year 2024, is expected to reach US$134.8 Billion by 2030, growing at a CAGR of 9.9% over the analysis period 2024-2030. In-house, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$81.7 Billion by the end of the analysis period. Growth in the Outsourcing segment is estimated at 12.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$20.9 Billion While China is Forecast to Grow at 13.2% CAGR

The Unit Dose Manufacturing market in the U.S. is estimated at US$20.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$27.2 Billion by the year 2030 trailing a CAGR of 13.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.2% and 8.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.7% CAGR.

Global Unit Dose Manufacturing Market - Key Trends & Drivers Summarized

Is the Shift Toward Precision Dosing Redefining the Pharmaceutical Packaging Landscape?

The rising emphasis on medication safety, dosing accuracy, and regulatory compliance is rapidly propelling the adoption of unit dose manufacturing across pharmaceutical and healthcare sectors. Unit dose packaging involves individually packaged and labeled doses of medications, typically designed for single-use, which enhances patient safety and reduces the risk of medication errors. This format has become especially crucial in hospital and long-term care settings where accurate dispensing plays a critical role in improving treatment outcomes and minimizing adverse drug events. With healthcare systems around the world increasingly embracing lean operations, automation, and digitization, unit dose manufacturing is gaining traction as a cornerstone of efficient medication management. Pharmaceutical companies, contract manufacturing organizations (CMOs), and healthcare institutions are investing in automated unit dose production systems that can handle diverse dosage forms-ranging from oral solids to injectables and inhalables. The format’s compatibility with barcode scanning, electronic health records (EHRs), and medication tracking systems further enhances its appeal. As regulatory bodies tighten controls around labeling, traceability, and supply chain transparency, unit dose manufacturing is emerging as an essential component of modern pharmaceutical logistics.

Why Are Patient Safety and Hospital Efficiency Fueling the Surge in Unit Dose Packaging?

Hospitals, clinics, and ambulatory care centers are under increasing pressure to reduce medical errors, streamline workflow, and optimize medication administration processes. Unit dose packaging directly supports these goals by providing clearly labeled, tamper-evident, ready-to-use medication units that minimize manual handling by healthcare providers. This is particularly significant in high-volume settings like inpatient wards and emergency rooms, where time-sensitive medication administration and staff workload are major concerns. Unit dose formats also allow healthcare staff to quickly verify correct dosages using barcodes, reducing the potential for cross-contamination or incorrect administration. Moreover, as medication regimens become increasingly personalized and complex, unit dose systems offer the flexibility to tailor treatments to individual patient needs without reliance on bulk packaging or manual preparation. In pediatric and geriatric care-where accurate dosing is especially critical-unit dose solutions improve safety, simplify compliance, and lower risk. Additionally, the unit dose model supports inventory control and waste reduction, offering hospitals a way to manage pharmaceutical costs while maintaining quality of care. These combined benefits are prompting healthcare providers to integrate unit dose formats into both acute and chronic care delivery models, thereby accelerating demand across institutional healthcare settings.

Can Automation and Smart Packaging Technologies Transform Unit Dose Manufacturing?

Technological innovation is playing a transformative role in scaling and modernizing unit dose manufacturing capabilities. Automation is at the forefront, with packaging lines now capable of high-speed filling, labeling, sealing, and inspection of individual units with minimal human intervention. Robotic systems and AI-enabled vision inspection tools ensure consistent quality control, while modular production lines allow rapid reconfiguration to accommodate various drug forms and packaging specifications. Smart packaging technologies are also being incorporated into unit dose formats, including RFID tags, QR codes, and time-temperature indicators, which enable real-time tracking and verification throughout the supply chain. These features enhance patient safety, improve inventory visibility, and support compliance with anti-counterfeiting regulations. Digital integration with hospital EHRs and pharmacy management software allows for seamless alignment between prescribing, dispensing, and administration, further reducing errors and increasing efficiency. On the sustainability front, manufacturers are exploring biodegradable films and recyclable materials to align unit dose packaging with environmental goals. These advancements are making unit dose manufacturing more adaptable, efficient, and intelligent-helping pharmaceutical companies and healthcare systems meet evolving expectations for safety, traceability, and operational excellence.

What Is Driving the Growth of the Global Unit Dose Manufacturing Market?

The growth in the unit dose manufacturing market is driven by several factors closely tied to technology integration, evolving healthcare practices, regulatory dynamics, and patient safety imperatives. A central growth driver is the global shift toward error-free, automated medication administration in hospitals and long-term care settings, where the need for accurate dosing and traceable dispensing is paramount. The expansion of outpatient and home healthcare services is also fueling demand for convenient, pre-measured, single-use medication formats that reduce complexity for patients and caregivers. Pharmaceutical manufacturers are increasingly partnering with CMOs specializing in unit dose production to meet demand without overburdening internal operations, especially for high-risk and high-volume drugs. Regulatory mandates on drug labeling, serialization, and safety packaging are further accelerating adoption, particularly in North America and Europe. In parallel, technological advances in packaging automation, smart tracking, and data integration are improving scalability and making unit dose manufacturing accessible to a wider range of pharmaceutical firms. Rising focus on cost efficiency and waste reduction in institutional settings is another key factor, with unit dose packaging proving effective in inventory control and resource optimization. As health systems pursue safer, more efficient medication delivery models, these forces are collectively propelling sustained growth in the global unit dose manufacturing market.

SCOPE OF STUDY:

The report analyzes the Unit Dose Manufacturing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Sourcing (In-house, Outsourcing); Product (Liquid Unit Dose, Solid Unit Dose, Others); End-Use (Independent Pharmacies, Long Term Care Facility, Hospitals, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Advanced Radiant Systems
  • Advanced Distributor Products (ADP)
  • Airtherm
  • Armstrong International Inc.
  • Beacon Morris
  • Brasch Manufacturing Company, Inc.
  • Daikin Industries Ltd.
  • Detroit Radiant Products
  • Dunham-Bush Limited
  • Goodman Manufacturing
  • Johnson Controls International Plc
  • KING ELECTRICAL MFG. CO
  • Kroll Energy GmbH
  • Lennox International Inc.
  • LG Electronics Inc.
  • Marley Engineered Products
  • Mitsubishi Electric Corporation
  • Modine Manufacturing Company
  • New York Blower Company
  • Reznor (Nortek Global HVAC)
  • Rheem Manufacturing Company
  • Trane Technologies plc

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Unit Dose Manufacturing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Emphasis on Medication Accuracy and Patient Safety Drives Adoption of Unit Dose Packaging
    • Rising Demand for Hospital and Institutional Pharmacy Automation Strengthens Business Case for Unit Dose Manufacturing
    • Stringent Regulatory Requirements for Drug Traceability and Labeling Propel Market Growth
    • Expansion of Geriatric and Chronic Disease Populations Spurs Demand for Pre-Measured, Easy-to-Use Dosage Forms
    • Increased Focus on Reducing Medication Errors in Clinical Settings Accelerates Use of Unit Dose Systems
    • Growth in Outpatient and Home Healthcare Services Expands Need for Portable, Single-Dose Packaging
    • Technological Advancements in Packaging Machinery and Serialization Drive Efficiency and Compliance
    • Integration with Electronic Medical Records (EMR) and Barcode Systems Enhances Dose-Level Tracking
    • Adoption of Lean Manufacturing and Just-In-Time Inventory Strategies Supports Scalable Unit Dose Production
    • Pharmaceutical Companies' Shift Toward Patient-Centric Drug Delivery Models Fuels Demand for Unit Dose Formats
    • Global Push for Antimicrobial Stewardship and Infection Control Highlights Benefits of Single-Use Dosing
    • Emerging Markets' Healthcare Infrastructure Development Expands Opportunities for Unit Dose Deployment
    • Increased Outsourcing of Pharmaceutical Packaging Services Drives Specialized Unit Dose Contract Manufacturing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Unit Dose Manufacturing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Unit Dose Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Unit Dose Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for In-house by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for In-house by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for In-house by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Liquid Unit Dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Liquid Unit Dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Liquid Unit Dose by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Solid Unit Dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Solid Unit Dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Solid Unit Dose by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Independent Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Independent Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Independent Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Long Term Care Facility by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Long Term Care Facility by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Long Term Care Facility by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Unit Dose Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Unit Dose Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Unit Dose Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Unit Dose Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Unit Dose Manufacturing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Unit Dose Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Unit Dose Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Unit Dose Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Unit Dose Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Unit Dose Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Unit Dose Manufacturing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Unit Dose Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Unit Dose Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Unit Dose Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Unit Dose Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Unit Dose Manufacturing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Unit Dose Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Unit Dose Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Unit Dose Manufacturing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Unit Dose Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Unit Dose Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제